Ian Li is a healthcare investor at 1315 Capital, specializing in providing growth capital to commercial-stage healthcare companies in various sectors. They have extensive experience in healthcare management and strategy consulting, with a focus on areas such as oncology and global market access. Ian served as a Board Observer for several companies, including CHC Solutions, NutriSense, and Bonafide Health, and currently holds board positions with miraDry, 3B Scientific, and CortiCare. A graduate of Duke University with a degree in biomedical engineering and a minor in economics, Ian has also worked in consulting and quality systems at Capgemini and Stryker, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices